A new instagram channel shows off graphic art featuring the antiviral oral supplement, Gene-Eden-VIR.

ROCHESTER, NEW YORK, UNITED STATES OF AMERICA, December 31, 2015 /EINPresswire.com/ --

The Center for the Biology of Chronic Disease (CBCD) points out a new Instagram channel, which features graphic designs by Taylor Barnes, an artist who combines images of Gene-Eden-VIR, an all natural antiviral product, with various images designed to evoke a particular feeling in the viewer.

“I think of my designs as integrations of wildly differing elements, all with the purpose of drawing the viewers eye to the Gene-Eden-VIR bottle. I found out about this product, which you know, is antiviral, and I thought it was uber cool. I feel that it’s amazing that it’s all natural and actually has science backing it with clinical studies. After I learned about it, I wanted to get others to pay attention to it too, so I began incorporating it into art that I was working on. Every piece is a bit improvisational, using some ready made images combined with my own touches of lighting and schematic themes. I want to emphasize Gene-Eden-VIR in a fun, inviting way. I feel like each design has the potential to appeal to a different kind of person. I had fun making them, and I invite people to share my designs with their friends. Sharing may actually have a positive impact on public health." - Taylor Barnes

The new Instagram channel can be seen here:
https://www.instagram.com/gene_eden_vir/

When discussing Gene-Eden-VIR and the clinical studies that back its antiviral formula, Mr. Barnes is referring to two separate post-marketing clinical studies that followed FDA guidelines. These found that the Gene-Eden-VIR formula reduces symptoms associated with certain viruses, such as the herpes simplex virus and the human papillomavirus (HPV), among others.

Additionally, the formula of these products was designed to help boost the immune system, and target the latent form of these viruses.

The formula of Gene-Eden-VIR was tested by Hanan Polansky and Edan Itzkovitz from the CBCD. The studies showed that the Gene-Eden-VIR formula is effective against the family of herpes viruses, including HSV-1 and HSV-2 (and other viruses). The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with (HSV-1 or HSV-2)…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (1) The study authors also wrote that, “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (1)

Gene-Eden-VIR can be ordered on its website, here:

http://www.gene-eden-vir.com

Gene-Eden-VIR is a natural antiviral dietary supplement. Its formula contains five natural ingredients: Selenium, Camellia Sinensis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach.

Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses.

To date, Gene-Eden-VIR and its sister product, Novirin, are the only natural antiviral products on the market with published clinical studies that support their claims.

“We love the images put together by Mr. Barnes. We hope the public agrees with us and chooses to share this artist’s designs with each other.” – Greg Bennett, CBCD

Find us on Facebook here: https://www.facebook.com/GeneEdenVIR
Follow us Twitter here: @HananPolansky

All orders of Gene-Eden-VIR and Novirin are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101

Greg Bennett
CBCD
585-250-9999
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.